CClinicalTrials.gg
RecruitingNCT07208812Updated Jan 29, 2026

3D-Printed Implant Overdentures: Comparing Impression Techniques

An interventional study of Conventional open -tray impression and Functionally generated reline impression in Edentulism, sponsored by Mansoura University. Recruiting at 1 site in Egypt. Open to participants aged 45 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-29.

Sponsored by Mansoura University · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Started Jan 2026; still recruiting 9 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Randomized
Ages
45 Years and older
Sex
All
01

Study summary

This randomized crossover clinical trial aims to compare three different impression techniques for the construction of 3d-printed mandibular implant overdentures in completely edentulous patients. Sixteen patients will receive two mandibular implants and three overdentures fabricated using:(1) conventional open-tray implant level impression (2) functionally generated reline impression, and (3)mucostatic base with functional borders impression. Each overdenture will be worn for three months with a washout period between interventions.

The primary outcome is masticatory efficiency, assessed using a color -mixing ability test at 3,6, and9 months.

Secondary outcome is patient satisfaction, assessed using a Visual Analog Scale (VAS) at the same intervals. the study hypothesis is that the impression technique influences both chewing efficiency and patient satisfaction

Read the detailed description

Edentulism has a significant impact on oral function and quality of life. The use of mandibular implant overdentures supported by two implants is widely considered the minimum standard of care, providing improved stability, function, and patient satisfaction compared with conventional complete dentures. Recently, digital workflows and additive manufacturing (3D printing) have created new opportunities for fabricating complete dentures with improved efficiency and reduced costs.

Several impression techniques are currently available for implant-retained overdentures, but there is limited evidence on how these techniques influence functional outcomes and patient-reported satisfaction, particularly when using 3D-printed prostheses.

This randomized crossover clinical trial will be conducted at the Faculty of Dentistry, Mansoura University. Sixteen completely edentulous patients aged 45-70 years will receive two implants placed in the mandibular canine region. After the osseointegration period, each participant will be provided with three different mandibular implant overdentures fabricated using different impression techniques:

  1. Conventional open-tray implant-level impression
  2. Functionally generated reline impression
  3. Mucostatic base with functional borders impression Each overdenture will be worn for a period of three months, with a two-week washout period using a provisional denture before switching to the next overdenture. Randomization will determine the sequence of interventions for each patient.

The primary outcome is masticatory efficiency, measured with a color-mixing ability test at 3, 6, and 9 months. The secondary outcome is patient satisfaction, measured using a Visual Analog Scale (VAS) at the same intervals.

The study is designed to provide evidence on whether the choice of impression technique affects clinical and patient-centered outcomes in 3D-printed mandibular implant overdentures.

02

Conditions studied

  • Edentulism

Browse trials for

Keywords

  • 3D-Printed Implant Overdenture
  • Impression Techniques
  • Chewing Efficiency
  • Patient Satisfaction
03

In context

Patient Satisfaction

256 studies on the registry are indexed under Patient Satisfaction; 127 are open to participants now.

This study's planned enrollment of 16 is below the median of 90 across 196 interventional studies indexed under Patient Satisfaction.

Browse Patient Satisfaction studies →

Lead sponsor

Mansoura University is the lead sponsor of 1,077 studies on the registry; 183 are open to participants now.

Of its 9 completed or terminated interventional studies of FDA-regulated products, 0 (0%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
45 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Healthy patients, free from systemic diseases that affect bone resorption (e.g., uncontrolled diabetes, osteoporosis)
  • Residual alveolar ridges covered with healthy, firm mucosa
  • Adequate mandibular bone length and width to accommodate standard implant sizes.
  • Angle's Class I maxillo-mandibular relationship.

Exclusion criteria

Exclusion Criteria:

  • Absolute contraindications to implant placement (e.g., active cancer, immune system diseases)
  • History of head and neck irradiation or chemotherapy within the past 3 years
  • Metabolic bone diseases such as uncontrolled diabetes, osteoporosis, or hyperparathyroidism
  • Parafunctional habits such as bruxism or clenching
  • Smoking or alcoholism
  • Any physical or medical condition that may interfere with study follow-up or implant success
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
16 participants (estimated)

Study arms

  • Experimental
    conventional open -tray impression

    Mandibular implant overdenture fabricated using the conventional open tray impression technique at the implant level.

    Procedure: Conventional open -tray impression

  • Experimental
    Functionally generated reline impression

    Mandibular implant overdenture fabricated using functionally generated reline impression technique.

    Procedure: Functionally generated reline impression

  • Experimental
    Mucostatic base with functional borders impression

    Mandibular implant overdenture fabricated using mucostatic base and functional borders impression technique.

    Procedure: Mucostatic base with functional borders impression

Interventions

  • ProcedureConventional open -tray impression

    Primary impression with irreversible hydrocolloid, custom tray with open window, and final impression with silicone material around impression copings to fabricate a 3D-printed implant overdenture

  • ProcedureFunctionally generated reline impression

    Interim prosthesis relieved and reline impression taken during centric closure with border molding, scanned to construct a 3D-printed implant overdenture

  • ProcedureMucostatic base with functional borders impression

    Intraoral scan of edentulous arch, 3D-printed baseplates for occlusion rim, functional border molding, and digital workflow to fabricate 3D-printed implant overdenture

06

What researchers measure

Primary outcomes

  1. Masticatory efficiency

    Assessment of chewing efficiency using a color- mixing ability test

    Time frame: 3, 6, and 9 months after overdenture insertion

Secondary outcomes

  1. Patient satisfaction

    Patient- reported satisfaction measured using the Visual Analog Scale

    Time frame: 3, 6, and 9 months after overdenture insertion

07

Study locations

1 of 1 sites recruiting
  • Faculty of Dentistry, Mansoura University
    Al Mansurah, Dakahlia Governorate 35516, Egypt
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 29, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07208812
Lead sponsor
Mansoura University
Responsible party
Shimaa Ebrahim Abo Elenin Ebrahim (Clinical demonstrator at prosthodontics department, Mansoura University) — Principal investigator
First posted
Oct 6, 2025
Start date
Jan 6, 2026
Primary completion
Apr 30, 2027 (estimated)
Completion
May 31, 2027 (estimated)
Last update
Jan 29, 2026

Study contacts

Shimaa E Aboelenin
Contact
shimaaaboelenin@mans.edu.eg
01113786860
Shimaa E Aboelenin
principal investigator · Faculty of Dentistry, Mansoura University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion